1 day ago · Merck KGaA SpringWorks Therapeutics mergers and acquisitions M&A. As SpringWorks Therapeutics nears a key regulatory decision in the U.S., the Connecticut-based cancer and rare disease drugmaker ...

1 day ago · Merck KGaA , the German healthcare and technology group, said on Monday it is in advanced talks to acquire U.S. cancer and rare diseases drugmaker SpringWorks Therapeutics .

12 hours ago · On Monday, Germany-based Merck KGaA (OTC:MKGAF) (OTC:MKKGY) reacted to press reports and confirmed advanced discussions with SpringWorks Therapeutics Inc (NASDAQ:SWTX), which has a market ...

Springworks' shares were trading 34% higher after Merck's statement, giving the company a market valuation of around $4 billion. The stock had initially jumped nearly 49% on the Reuters story, to ...

1 day ago · Merck KGaA said it’s in advanced talks to purchase SpringWorks Therapeutics Inc., sending shares of the US cancer and rare diseases drugmaker soaring.. One of SpringWorks’ drugs, Ogsiveo, is ...

2 days ago · Merck, in a statement, said its negotiations to buy SpringWorks are ongoing, confirming an earlier report from Reuters. The Darmstadt, Germany-based company said that no legally binding agreement ...

16 hours ago · German pharma Merck KGaA is currently in “ advanced discussions ” with SpringWorks Therapeutics regarding a potential acquisition. The news, first reported by Reuters Monday and confirmed by Merck KGaA a few hours later, sent the cancer biotech’s stocks soaring 34% and brought its value to approximately $4 billion at market close.

Shares in SpringWorks jumped Monday after Reuters reported that the company was in talks with Merck, closing 34% higher. This gave the Stamford, Conn.-based company a market value of $4.02 billion ...

Germany’s Merck MRK0.26%increase; green up pointing triangle KGaA said it is in advanced talks for a potential acquisition of SpringWorks Therapeutics SWTX-3.70%decrease; red down pointing ...

1 day ago · Shares of SpringWorks Therapeutics soared on Monday following a report that German medical firm Merck KGaA could acquire the company. A deal between the German company and the U.S.-based cancer ...